Dr. Bajor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3951Fax+1 216-844-5759
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
- Case Western Reserve University School of MedicineClass of 2007
Certifications & Licensure
- OH State Medical License 2016 - 2025
- PA State Medical License 2007 - 2016
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer Start of enrollment: 2016 Sep 12
Publications & Presentations
PubMed
- 2 citationsDevimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: ...Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi
Journal of Clinical Oncology. 2024-11-01 - 3 citationsOutcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.Kavin Sugumar, Henry Stitzel, Victoria Wu, David Bajor, Sakti Chakrabarti
Annals of Surgical Oncology. 2024-07-01 - ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review a...Kavin Sugumar, Henry Stitzel, Victoria Wu, David Bajor, Sakti Chakrabarti
Annals of Surgical Oncology. 2024-07-01
Press Mentions
- Combining Two Cancer Drugs Can Be Effective in Treating Specific Type of Colorectal Cancer, Study ShowsMay 2nd, 2022
- Adoptive Cell TherapyDecember 12th, 2018
- Immunotherapy Combo Appears Safe, Shrinks Metastatic Melanoma TumorsJune 2nd, 2015
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: